Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics

Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease that affects over 30% of the world’s population. For decades, the heterogeneity of non-alcoholic fatty liver disease (NAFLD) has impeded our understanding of the disease mechanism...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Yuxiao Jiang, Lili Wu, Xiaopeng Zhu, Hua Bian, Xin Gao, Mingfeng Xia
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2024-04-01
Sarja:	Lipids in Health and Disease
Aiheet:	Metabolic dysfunction-associated fatty liver disease Hepatic lipid metabolism Multisystem disease Pathophysiology Medications Clinical trials
Linkit:	https://doi.org/10.1186/s12944-024-02092-2
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!